| Open | 110.3 |
| LTP | 108 |
| Previous Close | 109.65 |
| Day High | 111 |
| Day Low | 105.25 |
| Volume | 14203 |
| Code : | MITSU |
| Name : | Mitsu Chem Plast Ltd |
| Country : | India |
| Sector : | |
| Industry: | Specialty Chemicals |
| Market CAP : | 144 Cr |
| Stock P/E: | 16.54 |
| ROCE: | 10.48% |
| Book Value: | 68.11 |
| Dividend Yield : | 0.18% |
| Most Recent Quarter : | 2024-06-30 |
| Revenue/Sales TTM : | 317 Cr |
| Operating Margin TTM : | 0.0372% |
| Return On Equity TTM : | 0.1% |
| Profit Margin : | 0.03% |
| Market Capitalization : | 144 Cr |
| EBITDA : | 25 Cr |
| Book Value : | 68.11 |
| PERatio : | 16.54 |
| Dividend Share : | 0 |
| Earnings Share : | 6.41 |
| Gross Profit TTM : | 111 Cr |
| Quarterly Earnings Growth YOY : | -0.32% |
| Dividend Yield : | 0.0018% |
| Quarterly Revenue GrowthYOY : | 0.07 |
| Diluted Eps TTM : | 6.41 |
| Trailing PE : | 16.54 |
| Price Sales TTM : | 0.45 |
| Enter Prise Value : | 205 Cr |
| Enter Prise Value Ebidta : | 8.2601 |
| Forward PE : | 0 |
| Price Book MRQ : | 1.62 |
| Enter Prise Value Revenue : | 0.65 |
| Forward Annual Dividend Rate : | 0.2 |
| Payout Ratio : | 0.03 |
| Ex Dividend Date : | 2024-08-20 |
| Last Split Date : | 2020-01-28 |
| Forward Annual Dividend Yield : | 0.0018 |
| Dividend Date : | |
| Last Split Factor : | 3:1 |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 110.92 | 113.83 | 116.67 | 108.08 | 105.17 | 102.33 | 99.42 |
| Fibonacci | 112.03 | 114.39 | 117.78 | 108.64 | 106.28 | 102.89 | 100.53 |
| Camarilla | 110.88 | 113.81 | 116.63 | 108.06 | 105.13 | 102.31 | 99.38 |
| Classic | 113.18 | 114.96 | 118.93 | 109.21 | 107.43 | 103.46 | 101.68 |
| Days 50 Day MA |
110.56 |
| Days 200 Day MA |
110.56 |
| Days 52 Week High |
212.41 |
| Days 52 Week Low |
102.5 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Jun 2024 | 80 Cr | 77 Cr | 1 Cr | 0 | 2 Cr | 41 Lac | 0 | -2 Cr | 0 |
| Mar 2024 | 82 Cr | 76 Cr | 3 Cr | 0 | 1 Cr | 96 Lac | 0 | -2 Cr | 0 |
| Dec 2023 | 73 Cr | 67 Cr | 3 Cr | 0 | 2 Cr | 1 Cr | 0 | -2 Cr | 0 |
| Sep 2023 | 76 Cr | 72 Cr | 1 Cr | 0 | 2 Cr | 57 Lac | 0 | -2 Cr | 0 |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Mar 2024 | 311 Cr | 292 Cr | 9 Cr | 0 | 8 Cr | 3 Cr | 31 Lac | -8 Cr | 0 |
| Mar 2023 | 309 Cr | 286 Cr | 12 Cr | 0 | 6 Cr | 3 Cr | 27 Lac | -7 Cr | 0 |
| Mar 2022 | 258 Cr | 237 Cr | 12 Cr | 0 | 5 Cr | 5 Cr | 26 Lac | -5 Cr | 0 |
| Mar 2021 | 178 Cr | 160 Cr | 10 Cr | 0 | 6 Cr | 4 Cr | 23 Lac | -6 Cr | 0 |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2024 | 194 Cr | 101 Cr | 41 Cr | 115 Cr | 0 | 84 Cr | 79 Cr |
| Sep 2023 | 175 Cr | 84 Cr | 27 Cr | 110 Cr | 0 | 66 Cr | 65 Cr |
| Mar 2023 | 177 Cr | 89 Cr | 32 Cr | 115 Cr | 0 | 70 Cr | 62 Cr |
| Sep 2022 | 165 Cr | 85 Cr | 35 Cr | 107 Cr | 0 | 75 Cr | 57 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2024 | 194 Cr | 101 Cr | 41 Cr | 115 Cr | 0 | 84 Cr | 79 Cr |
| Mar 2023 | 177 Cr | 89 Cr | 32 Cr | 115 Cr | 0 | 70 Cr | 62 Cr |
| Mar 2022 | 144 Cr | 79 Cr | 29 Cr | 93 Cr | 0 | 58 Cr | 51 Cr |
| Mar 2021 | 125 Cr | 58 Cr | 23 Cr | 85 Cr | 0 | 48 Cr | 40 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Jun 2024 | 0 | 0 | 0 | 0 | 1 Cr | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 | 0 | 3 Cr | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 | 0 | 3 Cr | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 | 0 | 1 Cr | 0 | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Mar 2024 | 0 | 24 Lac | -9 Cr | -12 Cr | 9 Cr | 6 Cr | 12 Cr |
| Mar 2023 | 0 | 24 Lac | -3 Cr | -27 Cr | 12 Cr | 5 Cr | 28 Cr |
| Mar 2022 | 0 | 24 Lac | -7 Cr | -3 Cr | 12 Cr | 5 Cr | 5 Cr |
| Mar 2021 | 0 | 24 Lac | -10 Cr | -7 Cr | 10 Cr | 4 Cr | 6 Cr |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 139.10 | 139.45 | 139.95 | 140.50 |
141.05 |
141.60 | 142.10 | 142.45 |
| Date | Opening price | Closing price | Minimum price | Maximum price |
|---|---|---|---|---|
| 2025-01-15 | 106 | 104.75 | 102.5 | 110 |
| 2025-01-16 | 105.95 | 111.15 | 105.95 | 112 |
| 2025-01-17 | 108.55 | 109.95 | 108.15 | 113 |
| 2025-01-20 | 112.95 | 110.85 | 107.3 | 112.95 |
| 2025-01-21 | 116 | 109.65 | 108 | 116 |
Mitsu Chem Plast Limited, together with its subsidiaries, manufactures and markets plastic blow and injection molded products in India and internationally. The company offers products, including molded industrial packaging full open top drums, jerry cans, narrow and wide mouth drums, jars, containers, plastic clamps, plastic caps and closures, plastic bungs for barrels, metered dose inhalers, plastic construction blocks, and plastic hinges, as well as industrial packaging products for agrochemicals, pharma packaging, bulk drugs and fine chemicals, diagnostics, cosmetics, and consumable products. It also provides automotive components, such as tanks, snorkels, rain hood and air intakes, plastic pipes, and injection molded articles; infrastructural furniture products comprising plastic chair and seat shells, plastic stadium and chair seats, plastic chair parts, baby car seat shells, and bus seats; and healthcare furniture products, such as side railing, straight and curved head and leg bow, panel head and foot bow, panel grill head and foot bow, over bed table top, bed board plank, bed side locker part, bed liner, spine board and stretcher, head immobilizer, plastic CPR board, buffer wheel, and toilet seat products. In addition, the company offers medical devices, including pregnancy, malaria, and HIV kits, as well as inhalers. Mitsu Chem Plast Limited was incorporated in 1988 and is based in Mumbai, India.
| Open | 110.3 |
| LTP | 108 |
| Previous Close | 109.65 |
| Day High | 111 |
| Day Low | 105.25 |
| Volume | 14203 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Lloyds Steels Industries Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GMR Infrastructure Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3i Infotech Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company WIPRO |
LTP 307.75 |
Change 9.4 |
Gain 3.15 % |
|
Company TCS |
LTP 4156.55 |
Change 120.7 |
Gain 2.99 % |
|
Company KOTAKBANK |
LTP 1915 |
Change 21.7 |
Gain 1.15 % |
|
Company BAJAJFINSV |
LTP 1736.55 |
Change 19.55 |
Gain 1.14 % |
|
Company HDFCBANK |
LTP 1660.45 |
Change 18.05 |
Gain 1.1 % |
|
Company TATAMOTORS |
LTP 740.8 |
Change -19.95 |
Loss -19.95 % |
|
Company SBIN |
LTP 746.9 |
Change -12.15 |
Loss -12.15 % |
|
Company BPCL |
LTP 276.5 |
Change -3.7 |
Loss -3.7 % |
|
Company AXISBANK |
LTP 958.8 |
Change -11.4 |
Loss -11.4 % |
|
Company TATASTEEL |
LTP 128.57 |
Change -1.13 |
Loss -1.13 % |
Motilal Oswal's research report on Dixon TechnologiesDixon Technologies (Dixon) reported better-than-expected revenue and EBITDA, driven by strong performance of the mobile and EMS segment, while PAT stood lower than our estimates on higher depreciation, interest, and minority interest. The company’s revenue/EBITDA jumped 117%/112% YoY for 3QFY25. The mobile and EMS segment continues to benefit ...
Shares of Multi Commodity Exchange of India (MCX) crashed 10 percent on January 21. This comes after brokerage Morgan Stanley issued an 'underweight' call for the stock, stating that the firm's Q3 net profit has fallen below its estimate.At 11:20 am on January 21, MCX shares were trading nearly 11% lower at Rs 5,388 apiece.MCX had released its quarterly results for October-December in the post-mar...
Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target price of Rs 2,150, reflecting a 7 percent downside from the previous close.The international brokerage said that the domestic formulations business remains weak, driven by slower growth in acute therapies,...
The Q3 earnings season kicked off right in the middle of market chaos—caught between pre-budget buzz, US policy jitters, India’s faltering growth, and sky-high valuations. January, already cursed with weak seasonality, has been a rollercoaster of volatility, leaving investors in a pool of caution.One standout trend this season? Investors are getting seriously choosy. This marks a stark differe...
Sellwin Traders, which reported a 90 percent jump in income for the December quarter, on Sunday said it has signed a pact with UAE-based Secorbit FZCO for developing a blockchain-based tokenization platform for equities, bonds, and real-world assets for USD 3 million (around Rs 26 crore).The platform will be developed for Secorbit to “enable the tokenization of equities, bonds, and real-world as...
The FY22 long-term borrowing reduced by 10.67 per cent Y-o-Y to rs 28.55 Cr
Login & Reply Like(0) Dislike(0) Repost Spam
SEMU 2022-09-06 11:41:57
Company sales rising enabled company to report strong operating profitablity & increase in the operating efficiency
Login & Reply Like(0) Dislike(0) Repost Spam